The Lawyer: Top 20 cases of 2024

We are proud to be acting for BioNTech in UK patent litigation relating to the BioNTech/Pfizer Covid-19 vaccine, Comirnaty – the first vaccine treatment approved for emergency use in the pandemic – and to be supporting the litigation teams across Europe and in the US in cases involving mRNA technology patents asserted by Moderna and CureVac. 

The UK litigation with Moderna is featured in The Lawyer’s Top 20 litigation cases of 2024: here.

For more information about our IP litigation expertise in the life sciences / biotech sector, visit our website: here.